This joint program will lead to an M.S. in Biology (GSAS) and M.B.A. (Stern School of Business). This program meets a need for academic preparation and training of Scientist-Managers and Research Directors for the biotechnology and pharmacology industry, academic Industrial Liaison personnel, Investment Specialists for the financial sector, and Government Regulatory personnel.
Students will earn 30 credits in GSAS-Biology and complete a Qualifying Thesis as well as 54 credits at the Stern School of Business. This will be a full-time program, with students enrolled for the first year and summer at GSAS and the second and third years at Stern.
The GRE exam is required for the application process. Also accepted in lieu of the GRE are GMAT, LSAT, DAT, MCAT scores. Each program's prerequisites remain; for instance Stern considers business experience essential and Biology requires the pre-medical core curriculum to matriculate in graduate level courses. Admissions are made by each school's admissions committee and students must be admitted to both programs to qualify for the joint degree.
For the M.S. in Biology portion of the program, students typically take BioCore I and II (BIOL-GA.1001 and 1002), and biology electives related to health and medicine such as Metabolic Disorders (BIOL-GA.1032), Emerging Pathogens (BIOL-GA.1080), Hot Topics in Infectious Disease (BIOL-GA.1023), and Toxicology (BIOL-GA.1006). A sample program of study is available.